Skip to main content
Log in

The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Monoclonal antibodies (MAbs) to 2 epitopes on the haemagglutininneuraminidase (HN) protein of the Ulster strain of Newcastle disease virus neutralized synergistically: MAbs to HN-1 and HN-2 neutralized 1.2 and 1.7 log10 infectious units (i. u.) of virus when single as compared to 4.1 when combined. Although MAb to HN-1 but not to HN-2 inhibited haemagglutination they both neutralized more virus on desialized cells compared to normal cells and were considered to have interfered with viral attachments in a cooperative manner when combined. A third MAb to fusion (F) protein reduced infectivity by five log10 i. u. HN-1, HN-2 and F were not the only immunodominant epitopes because mutants, which simultaneously lacked all 3 epitopes, were indistinguishable from wild type when neutralized by polyclonal mouse, rabbit or chicken antiserum to whole virus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Avery, R. J., Niven, J.: Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations. Infect. Immun.26, 795–801 (1979).

    Google Scholar 

  2. Granoff, A.: Heterozygotes and phenotypic mixing of Newcastle Disease Virus. Cold Spring Harbor Symposium on Quantitative Biology27, 319–326 (1962).

    Google Scholar 

  3. Iorio, R. M., Bratt, M. A.: Monoclonal antibodies to Newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J. Virol.48, 440–450 (1983).

    Google Scholar 

  4. Iorio, R. M., Bratt, M. A.: Neutralization of Newcastle Disease Virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. J. Virol.51, 445–451 (1984).

    Google Scholar 

  5. Kingsford, L., Ishizawa, L. D.: Antigenic sites on the G 1 glycoprotein of La Crosse virus that are involved in neutralization. In:Compans, R. W. L., Bishop, D. H. L. (eds.), Segmented Negative Strand Viruses, 217–224. New York: Academic Press 1984.

    Google Scholar 

  6. Lubeck, M., Gerhard, W.: Conformational changes to topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virology118, 1–7 (1982).

    Google Scholar 

  7. Marcus, P. I., Hirsh, D.: Renewal of a normal surface component: cellular receptors for virus attachment. J. Cell Biol.19, 47 A (1963).

    Google Scholar 

  8. McClelland, D. A. J.: Vaccination against paramyxoviruses. Nature (London)284, 404 (1980).

    Google Scholar 

  9. Miura, N., Uchida, T., Okada, Y.: HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit haemagglutination activity of HVJ. Exp. Cell Res.141, 409–420 (1982).

    Google Scholar 

  10. Nagai, Y., Klenk, H.-D., Rott, R.: Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle Disease Virus. Virology72, 494–508 (1976).

    Google Scholar 

  11. Nishikawa, K., Isomura, S., Suzuki, S., Watanabe, E., Hamaguchi, M., Yoshida, M., Nagai, Y.: Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus, biological characterization and use for strain comparisons. Virology130, 318–330 (1983).

    Google Scholar 

  12. Possee, R. D., Schild, G. C., Dimmock, N. J.: Studies on the mechanisms of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virusin vivo by inhibiting virion Transcriptase activity. J. gen. Virol.58, 373–386 (1982).

    Google Scholar 

  13. Russell, P. H.: Augmentation of the antibody forming cell response to neuraminidase-treated cells by myxoviruses. Immunology44, 781–787 (1981).

    Google Scholar 

  14. Russell, P. H.: Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants. J. gen. Virol.65, 795–798 (1984).

    Google Scholar 

  15. Russell, P. H.: Newcastle disease virus and two influenza viruses: Differing effects of acid and temperature on the uptake of infectious virus into bovine and canine kidney cell lines. Arch. Virol.88, 159–166 (1986).

    Google Scholar 

  16. Russell, P. H., Alexander, D. J.: Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies. Arch. Virol.75, 243–253 (1983).

    Google Scholar 

  17. Russell, P. H., Griffiths, P. C., Cannon, M. J.: A microwell immunoperoxidase test for screening hybridomas and for diagnosing Newcastle disease virus and Sendai virus. J. Immun. Meth.61, 165–170 (1983).

    Google Scholar 

  18. Russell, P. H., Griffiths, P. C., Goswami, K. K. A., Alexander, D. J., Cannon, M. J., Russell, W. C.: The characterization of monoclonal antibodies to Newcastle disease virus. J. gen. Virol.64, 2069–2072 (1983).

    Google Scholar 

  19. Smith, G. W., Hightower, L. E.: Biological consequences of neuraminidase deficiency in Newcastle disease virus. J. Virol.47, 385–391 (1983).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

With 2 Figures

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, P.H. The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein. Archives of Virology 90, 135–144 (1986). https://doi.org/10.1007/BF01314151

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01314151

Keywords

Navigation